The Medical Letter, Inc. is a nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases in its newsletter, The Medical Letter on Drugs and Therapeutics. It also includes new information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings. Particular attention is paid to clinical efficacy, adverse effects, drug interactions, and cost. Our publication is intended specifically to meet the needs of busy healthcare professionals who want unbiased, reliable and timely drug information. The editorial process used relies on a consensus of experts to evaluate the drug facts in order to help prescribers choose the most effective drug treatment. We are committed to providing accurate information on drugs and treatments of choice and helping our readers make the best decisions for the patient—without the influence of the pharmaceutical industry or any other commercial entity. This commitment to unbiased drug information ensures that subscribers can rely on our content as a crucial resource of objective, unbiased drug information–free of advertising and commercial influence. The Medical Letter is funded by subscriber fees and donations.